Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2008
12/09/2008US7462628 Preventives/remedies for urinary disturbance
12/09/2008US7462622 Pyrrolo[2, 3-d] pyrimidine derivatives as corticotropin releasing factor antagonists
12/09/2008US7462621 9-[3-(2-Fluorophenyl)-propyl]-7,7-dimethyl-2-(pyridin-4-yl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; neurodegenerative disease caused by abnormal activity of GSK3 beta (glycogen synthase kinase beta 3) or GSK3 beta and cdk5/p253
12/09/2008US7462620 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
12/09/2008US7462616 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
12/09/2008US7462608 Non nucleoside reverse transcriptase inhibitors
12/09/2008US7462606 Antiseptics; surgery; controlling release of drugs
12/09/2008US7462597 Corticotropin releasing factor 2 receptor agonists
12/09/2008US7462366 Drug delivery particle
12/09/2008US7462360 for induction of interferon/natural killer cell activity; for treating viral/fungal systemic infections, or oncological diseases
12/09/2008US7462357 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
12/09/2008US7462354 Storing a plurality of input parameters in a memory of a computer system, generating a list of epitope pairs from epitopes; determining for each epitope pairs at least one optimum combination of amino acid insertions; identifying
12/09/2008CA2425368C New sulphoxybenzamides
12/09/2008CA2415447C Novel .gamma. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
12/09/2008CA2388142C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
12/09/2008CA2379061C Antibacterial agents
12/09/2008CA2352054C New amidino derivatives and their use as thrombin inhibitors
12/09/2008CA2337804C Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
12/09/2008CA2326045C Pde iv inhibiting pyridine derivatives
12/09/2008CA2323805C Analgesic combination comprising nmda receptor antagonists and narcotic analgesics
12/09/2008CA2321728C Epiallopregnanolone in the treatment of cns disorders
12/09/2008CA2294059C New amidino derivatives and their use as thrombin inhibitors
12/09/2008CA2286913C Composition and methods using an eutomer
12/04/2008WO2008147168A1 Use of 5-methyl-1-phenyl-2-(1h)-pyridone for the treatment of the adverse effects of breast implants, such as inflammation, contraction of the capsule and fibrosis
12/04/2008WO2008146907A1 Oral composition
12/04/2008WO2008146871A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity
12/04/2008WO2008145697A1 Cancer treatment combination therapy comprising vinflunine and trastuzumab
12/04/2008WO2008144982A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
12/04/2008WO2008028193A3 Colon-targeted oral formulations of cytidine analogs
12/04/2008WO2007095497A3 Compositions and methods for prevention and treatment of cachexia
12/04/2008WO2007092496A3 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors
12/04/2008WO2007092161A3 A direct cellular energy delivery system
12/04/2008WO2007089862A3 Alpha-synuclein kinase
12/04/2008US20080300407 Pyridinoylpiperidines as 5-HT1F agonists
12/04/2008US20080300322 Delivery vehicles containing rosin resins
12/04/2008US20080300271 Novel compounds and a novel process for their preparation
12/04/2008US20080300255 Substituted pyrazoles
12/04/2008US20080300249 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
12/04/2008US20080300241 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
12/04/2008US20080300202 Subtractive transgenics
12/04/2008US20080300194 Methods of treating emesis using growth hormone secretagogues
12/04/2008US20080300167 Patched genes and uses related thereto
12/04/2008US20080299596 Substrates and assays for beta-secretase activity
12/04/2008US20080299582 Culture System for Rapid Expansion of Human Embryonic Stem Cells
12/04/2008US20080299536 Material and Methods for Nerve Grafting
12/04/2008US20080299239 Inhibitor of Glucose Absorption and Method for Producing the Same
12/04/2008US20080299235 Methods of lowering blood cholesterol via oral fenugreek seed extract compositions
12/04/2008US20080299210 Stable nanosized amorphous drug
12/04/2008US20080299202 Controlled-Delivery System of Pharmacologically Active Substances, Preparation Process and Medical Use Thereof
12/04/2008US20080299190 Direct Compression Formulation and Process
12/04/2008US20080299170 Medical Devices and Coatings Therefor
12/04/2008US20080299168 Stabilized Polymeric Delivery System
12/04/2008US20080299142 Compounds and methods for treatment and diagnosis of chlamydial infection
12/04/2008US20080299139 Mammalian cytokines; related reagents and methods
12/04/2008US20080299134 Recombinant Anti-Interleukin-9 Antibodies
12/04/2008US20080299133 Anti-Il-12 Antibody Based Vectors, Host Cells, and Methods of Production and Uses
12/04/2008US20080299126 Having high affinity and may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof; useful for increasing muscle mass, increasing bone density, or for the treatment of various disorders in mammalian and avian species
12/04/2008US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof
12/04/2008US20080299115 Antibody Variants with Faster Antigen Association Rates
12/04/2008US20080299107 Combinations of human proteins to enhance viability of transplanted stem cells and progenitor cells
12/04/2008US20080299099 Strain composition of the lactobacillus genus and the application of strain composition of the lactobacillus genus
12/04/2008US20080299097 Isolated population of rapidly proliferating marrow stromal cells for enhanced in vivo engraftment
12/04/2008US20080299096 Modified nucleotide sequence encoding glucagon-like peptide-1 (glp-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (glp-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereof
12/04/2008US20080299091 Patient-specific stem cell lines derived from human parthenogenetic blastocysts
12/04/2008US20080299084 Bacterially derived intact minicells that encompass plasma free functional nucleic acid for in vivo delivery to mammalian cells
12/04/2008US20080299044 Saccharide Fluorescent Substrates, Preparation Method and Uses Thereof
12/04/2008DE102007024852A1 Strongly enriching the amino acids and/or oligopeptides based on sweet whey powder, which is dissolved in water, comprises converting sugar to lactic acid and proteins to oligopeptides and amino acids using protease or lactic acid bacterium
12/04/2008CA2688495A1 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
12/04/2008CA2688293A1 Dietary formulations and methods for treatment of inflammation and other disorders
12/04/2008CA2687948A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein andhas glucocorticoid receptor-binding activity
12/03/2008EP1997823A1 Boronic ester and acid compounds, synthesis and uses
12/03/2008EP1997804A1 Mmp-13-selective inhibitor
12/03/2008EP1997534A1 Cancer treatment combination therapy comprising vinflunine and trastuzumab
12/03/2008EP1997512A2 Methods for treating TWEAK-related conditions
12/03/2008EP1997511A1 Therapeutic agent for rheumatoid arthritis
12/03/2008EP1997494A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto
12/03/2008EP1997490A1 Oral agent for promoting synthesis of tissue collagen
12/03/2008EP1997485A1 Pharmaceutical composition comprising meglitinide for prevention of hepatic fibrosis
12/03/2008EP1996202A1 Chemical compounds
12/03/2008EP1996179A2 Compositions for disorders associated with metachromatic cell activation
12/03/2008EP1513516B1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/03/2008EP1492785B1 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
12/03/2008EP1478366B1 Pharmaceutical combinations of meloxicam, codeine phosphate and paracetamol
12/03/2008EP1430031B1 Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
12/03/2008EP1423388B1 2-arylamino-pyrimidines for the treatment of gsk3-related disorders
12/03/2008EP1390045B1 The use of a compound with a negatively charged domain of phosphorous-containing radicals for the treatment of restenosis
12/03/2008EP1373218B9 Imidazolyl derivatives useful as histamine h3 receptor ligands
12/03/2008EP1305330B1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
12/03/2008EP1303293B1 Sequential administration of cpt-11 and apo-2l polypeptide
12/03/2008EP1250337B1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
12/03/2008EP1213975B1 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado
12/03/2008EP1121140B1 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease
12/03/2008EP1068202B1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists
12/03/2008EP0812208B1 Pharmaceutical compositions for controlled release of soluble receptors
12/03/2008CN101316591A Quinolines and their therapeutic use
12/03/2008CN101314046A Cyclodextrin inclusion method for hair orchid native
12/03/2008CN101314021A Chinese medicinal composition for dispelling wind and relieving paralysis
12/03/2008CN101314003A Ultra-high biomass macromolecule biological activity multimer traditional Chinese medicine preparation series for brain regeneration
12/03/2008CN101313964A Medicine for treating hydrocephalus
12/03/2008CN100439399C Human antibodies that bind human IL-12 and methods for producing
1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 1564